Contipharma Belgium

To develop and commercialize innovative medical solutions to address unresolved public health challenges, focusing our expertise on:

• R&D of next-generation non-invasive diagnostics;
• Accessibility to essential medicines in shortage situations or made inaccessible due to their cost.

Resolutely innovation-oriented, our diagnostic solutions represent an alternative that is both culturally acceptable and technologically advanced to conventional methods. They are specifically designed to meet the constraints of remote areas and the requirements of epidemic emergencies.

Each proposal integrates local realities in all their dimensions—economic, logistical, and cultural—thus ensuring products truly adapted to the needs of the populations concerned.

Committed to meeting the requirements of the World Health Organization (WHO), Contipharma relies on a network of leading scientific collaborations and works in close synergy with internationally recognized research institutions, including the National Institute for Biomedical Research (INRB) in Kinshasa, the University of Liège in Belgium, as well as an ecosystem of renowned European industrial laboratories.